Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world... Show more
HOCPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where HOCPF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on HOCPF as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HOCPF just turned positive on August 11, 2025. Looking at past instances where HOCPF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
HOCPF moved above its 50-day moving average on August 04, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HOCPF crossed bullishly above the 50-day moving average on July 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOCPF advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 228 cases where HOCPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HOCPF moved out of overbought territory on July 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOCPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOCPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.022) is normal, around the industry mean (10.930). P/E Ratio (34.434) is within average values for comparable stocks, (62.278). HOCPF's Projected Growth (PEG Ratio) (3.480) is slightly higher than the industry average of (1.881). Dividend Yield (0.008) settles around the average of (0.016) among similar stocks. P/S Ratio (7.855) is also within normal values, averaging (39.773).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
A.I.dvisor tells us that HOCPF and HOCPY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOCPF and HOCPY's prices will move in lockstep.
Ticker / NAME | Correlation To HOCPF | 1D Price Change % | ||
---|---|---|---|---|
HOCPF | 100% | N/A | ||
HOCPY - HOCPF | 25% Poorly correlated | +1.01% | ||
FZMD - HOCPF | 11% Poorly correlated | N/A | ||
IDTA - HOCPF | 5% Poorly correlated | N/A | ||
IRME - HOCPF | 1% Poorly correlated | N/A | ||
GNNDY - HOCPF | 0% Poorly correlated | +2.74% | ||
More |
Ticker / NAME | Correlation To HOCPF | 1D Price Change % |
---|---|---|
HOCPF | 100% | N/A |
Pharmaceuticals category (394 stocks) | 4% Poorly correlated | -1.04% |
Pharmaceuticals: Other category (105 stocks) | 1% Poorly correlated | -0.56% |